Scientific Advisory Board
Gary Ansel, M.D.Dr. Gary Ansel is an internationally renowned interventional expert, both in peripheral vascular and cardiovascular procedures. He has been appointed associate medical director of the OhioHealth Research and Innovation Institute in Columbus, Ohio and is a member of the OhioHealth Research Industry Council. He serves as a primary investigator for numerous national and international research trials, helping to improve care for patients suffering with peripheral and cardiovascular disease.
Elazar Edelman, M.D., Ph.D.
Dr. Elazer R. Edelman is the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology at MIT, professor of medicine at Harvard Medical School, and senior attending physician in the coronary care unit at the Brigham and Women’s Hospital (BWH) in Boston. He and his laboratory have pioneered basic findings in vascular biology and the development and assessment of biotechnology.
William Gray, M.D.
Dr. William Gray is system chief of the Division of Cardiovascular Disease at Main Line Health in Philadelphia. He is also the first president of Main Line Health’s Lankenau Heart Institute, the system’s comprehensive cardiovascular medicine and surgery program. Dr. Gray has served in cardiovascular leadership roles for nearly 20 years, most recently as director of endovascular services at New York-Presbyterian/Columbia University Medical Center,.
Larry Kraiss, M.D.
Larry W Kraiss MD is Professor of Surgery in the Division of Vascular Surgery at the University of Utah. He is a graduate of Vanguard University of Southern California (BA: Science-Chemistry) and Baylor College of Medicine (MD). He took his general and vascular surgical training at the University of Washington in Seattle where he also spent three years in the vascular biology research laboratory of Dr. Alexander Clowes. He joined the faculty at the University of Utah in 1995 where he established an NIH-funded research laboratory studying translational control in endothelial cells and was named vascular surgery division chief in 2003.
Krishna Rocha-Singh, M.D.
Dr. Krishna Rocha-Singh is chief scientific officer for Prairie Heart Institute at St. John’s Hospital in Springfield, Ill. In addition, he is a current co-founding board member of Vascular InterVentional Advances (VIVA), a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research.
William Sessa, Ph.D.
Dr. William Sessa is the Alfred Gilman Professor of Pharmacology and Professor of Medicine (Cardiology); the vice chairman, pharmacology; and the director, Vascular Biology & Therapeutics Program at Yale University. Dr. Sessa’s numerous honors include the American Heart Association’s Established Investigator Award; the Young Alumnus Award; the Experimental Therapeutics’ John J. Abel Award in Pharmacology, a MERIT Award; and The Robert Berne Award from the American Physiological Society.
Craig Walker, M.D.
Dr. Craig Walker is the founder and president of the Cardiovascular Institute of the South. Board certified in internal medicine, cardiovascular disease and interventional cardiology, he is a fellow of the American College of Cardiology, the American College of Physicians, the American Society of Cardiovascular Interventionists, the International College of Angiology, the Society for Cardiac Angiography and Interventions, the American College of Chest Physicians, and the Council on Clinical Cardiology.